AKT1 and multiple sclerosis: In addition, CXCR2 counteracts adult OPC differentiation and myelination potential, in a model of multiple sclerosis, by interfering with the PI3K/AKT/mTOR pathway, thereby strongly reinforcing the possibility of a role of cytokines and chemokines in OPC maturation blockade, during development [43].